Elizabeth Garofalo
Director/Board Member chez ACADIA PHARMACEUTICALS INC.
Fortune : 451 313 $ au 31/03/2024
Profil
Elizabeth A Garofalo currently works at ACADIA Pharmaceuticals, Inc., as Independent Director from 2020, Xenon Pharmaceuticals, Inc., as Independent Director from 2021, Alector, Inc., as Independent Director from 2021, Institute For Advanced Clinical Trials For Children, as Director, and EAG Pharma Consulting LLC, as Principal from 2016.
Dr. Garofalo also formerly worked at Exicure, Inc., as Chairman from 2022 to 2023, Pfizer Inc., as Head-Neuroscience & Worldwide Regulatory Affairs, Novartis International AG, as Global Head-Clinical Development & Senior VP, and Astellas Pharma Global Development, Inc., as VP & Head-Neuroscience Therapy Area.
Dr. Garofalo received her undergraduate degree from Purdue University and doctorate degree from The Indiana University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 24/11/2023 | 15 862 ( 0,01% ) | 293 288 $ | 31/03/2024 | |
ALECTOR, INC.
0,03% | 05/12/2023 | 26 250 ( 0,03% ) | 158 025 $ | 31/03/2024 |
| 08/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Elizabeth Garofalo
| Sociétés | Poste | Début |
|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Director/Board Member | 29/09/2020 |
| XENON PHARMACEUTICALS INC. | Director/Board Member | 03/06/2021 |
| ALECTOR, INC. | Director/Board Member | 28/09/2021 |
| EAG Pharma Consulting LLC | Corporate Officer/Principal | 01/01/2016 |
| Institute For Advanced Clinical Trials For Children | Director/Board Member | - |
Anciens postes connus de Elizabeth Garofalo
| Sociétés | Poste | Fin |
|---|---|---|
| EXICURE, INC. | Chairman | 24/02/2023 |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
| PFIZER, INC. | Corporate Officer/Principal | - |
Astellas Pharma Global Development, Inc.
 Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | Corporate Officer/Principal | - |
Formation de Elizabeth Garofalo
| Purdue University | Undergraduate Degree |
| The Indiana University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| PFIZER, INC. | Health Technology |
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| XENON PHARMACEUTICALS INC. | Health Technology |
| ALECTOR, INC. | Health Technology |
| EXICURE, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | Health Technology |
| Institute For Advanced Clinical Trials For Children | |
| EAG Pharma Consulting LLC |
